The expression and function of the OGF-OGFr axis - A tonically active negative regulator of growth - In COS cells

Neuropeptides

Volumn 37, Issue 5, 2003, Pages 290-297

  Zagon, Ian S ^a   Verderame, Michael F ^a   McLaughlin, Patricia J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

COS cells; Growth; Opioid growth factor; Opioid growth factor receptor; Opioid peptides; Opioid receptor; Preproenkephalin; Tissue culture

Indexed keywords

MESSENGER RNA; METENKEPHALIN; NALTREXONE;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

EID: 0345304353     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2003.07.001     Document Type: Article

References (29)

1. Bisignani, G.J., McLaughlin, P.J., Ordille, S.D., Beltz, M.S., Jarowenko, M.V., Zagon, I.S., 1999. Human renal cell proliferation in tissue culture is tonically inhibited by opioid growth factor. J. Urol. 162, 2186-2191.
2. Bottger, A., Spruce, B.A., 1995. Proenkephalin is a nuclear protein responsive to growth arrest and differentiation signals. J. Cell Biol. 130, 1251-1262.
3. Chen, Y., Mestek, A., Liu, J., Hurley, J.A., Yu, L., 1993. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
4. Comb, M., Seeburg, P.H., Adelman, J., Eiden, L., Herbert, E., 1982. Primary structure of the human Met-and Leu-enkephalin precursor and its mRNA. Nature 295, 663-666.
5. Gluzman, Y., 1981. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23, 175-182.
6. Kam, A.Y., Chan, A.S., Wong, Y.H., 2003. Rac and Cdc42-dependent regulation of c-Jun N-terminal kinases by the δ-opioid receptor. J. Neurochem. 84, 503-513.
7. Kong, H., Raynor, K., Yano, H., Takeda, J., Bell, G.I., Reisine, T., 1994. Agonists and antagonists bind to different domains of the cloned κ opioid receptor. Proc. Natl. Acad. Sci. USA 91, 8042-8046.
8. Leslie, F., 1987. Methods for the study of opioid receptors. Pharmacol. Rev. 39, 197-249.
9. Litt, M., Buroker, N.E., Kondoleon, S., Douglass, J., Liston, D., Sheehy, R., Magenis, R.E., 1988. Chromosomal localization of the human proenkephalin and prodynorphin genes. Am. J. Hum. Genet. 42, 327-334.
10. McLaughlin, P.J., Levin, R.J., Zagon, I.S., 1999. Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor. Int. J. Oncol. 14, 991-998.
11. Minami, M., Toya, T., Katao, K., Mackawa, K., Nakamura, S., Onogi, T., Kaneko, S., Satoh, M., 1993. Cloning and expression of a cDNA for the rat κ-opioid receptor. FEBS Lett. 329, 291-295.
12. Noda, M., Teranishi, Y., Takahasi, H., Toyosato, M., Notake, M., Nakanishi, S., Numa, S., 1982. Isolation and structural organization of the human preproenkephalin gene. Nature 297, 431-434.
13. -, and C2C12. Peptides 16, 935-938.
14. Terao, M., Watanabe, Y., Mishina, M., Numa, S., 1983. Sequence requirement for transcription in vivo of the human preproenkephalin A gene. EMBO J. 2, 2223-2228.
15. Yoshikawa, K., Williams, C., Sabol, S.L., 1984. Rat brain preproenkephalin mRNA. J. Biol. Chem. 259, 14301-14308.
16. Zagon, I.S., Gibo, D.M., McLaughlin, P.J., 1991. Zeta (ζ), a growth-related opioid receptor in developing rat cerebellum: identification and characterization. Brain Res. 551, 28-35.
17. Zagon, I.S., Goodman, S.R., McLaughlin, P.J., 1993. Zeta (ζ), the opioid growth factor receptor: Identification and characterization of binding subunits. Brain Res. 605, 50-56.
18. Zagon, I.S., Hytrek, S.D., McLaughlin, P.J., 1996. Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. Am. J. Physiol. 271, R511-R518.
19. Zagon, I.S., Isayama, T., McLaughlin, P.J., 1994. Preproenkephalin mRNA expression in the developing and adult rat brain. Mol. Brain Res. 21, 85-98.
20. Zagon, I.S., McLaughlin, P.J., 1993. Opioid growth factor receptor in the developing nervous system. In: Zagon, I.S., McLaughlin, P.J. (Eds.), Receptors in the Developing Nervous System. Growth Factors and Hormones, Vol. 1. Chapman & Hall, London, pp. 39-62.
21. Zagon, I.S., McLaughlin, P.J., 1989. Endogenous opioids regulate growth of neural tumor cells in culture. Brain Res. 490, 14-25.
22. 5]-enkephalin, and the etiology, pathogenesis, and treatment of gastrointestinal cancer. In: Plotnikoff, N.P., Faith, R.E., Murgo, A.J., Good, R.A. (Eds.), Cytokines-Stress and Immunity. CRC Press, Boca Raton, FL, pp. 245-260.
23. Zagon, I.S., McLaughlin, P.J., 2003. Opioids and the apoptotic pathway in human cancer cells. Neuropeptides 37, 79-88.
24. Zagon, I.S., Roesener, C.D., Verderame, M.F., Ohlsson-Wilhelm, B.M., Levin, R.J., McLaughlin, P.J., 2000c. Opioid growth factor regulates the cell cycle of human neoplasias. Int. J. Oncol. 17, 1053-1061.
25. Zagon, I.S., Ruth, T.B., Leure-duPree, A.E., Sassani, J.W., McLaughlin, P.J., 2003. Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea. Brain Res. 967, 37-47.
26. Zagon, I.S., Smith, J.P., Conter, R., McLaughlin, P.J., 2000a. Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma. Int. J. Mol. Med. 5, 77-84.
27. Zagon, I.S., Smith, J.P., McLaughlin, P.J., 1999. Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. Int. J. Oncol. 14, 577-584.
28. Zagon, I.S., Verderame, M.F., McLaughlin, P.J., 2002. The biology of the opioid growth factor (OGFr). Brain Res. Rev. 38, 351-376.
29. Zagon, I.S., Wu, Y., McLaughlin, P.J., 2000b. Opioid growth factor and organ development in rat and human embryos. Brain Res. 839, 313-322.